These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23782330)

  • 1. Bi-directional roles of bone morphogenetic proteins in cancer: another molecular Jekyll and Hyde?
    Ehata S; Yokoyama Y; Takahashi K; Miyazono K
    Pathol Int; 2013 Jun; 63(6):287-96. PubMed ID: 23782330
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Emerging roles of the bone morphogenetic protein pathway in cancer: potential therapeutic target for kinase inhibition.
    Jiramongkolchai P; Owens P; Hong CC
    Biochem Soc Trans; 2016 Aug; 44(4):1117-34. PubMed ID: 27528760
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Bone morphogenetic protein signaling enhances invasion and bone metastasis of breast cancer cells through Smad pathway.
    Katsuno Y; Hanyu A; Kanda H; Ishikawa Y; Akiyama F; Iwase T; Ogata E; Ehata S; Miyazono K; Imamura T
    Oncogene; 2008 Oct; 27(49):6322-33. PubMed ID: 18663362
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone morphogenetic proteins in tumour associated angiogenesis and implication in cancer therapies.
    Ye L; Jiang WG
    Cancer Lett; 2016 Oct; 380(2):586-597. PubMed ID: 26639195
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone morphogenetic proteins and cancer: review of the literature.
    Thawani JP; Wang AC; Than KD; Lin CY; La Marca F; Park P
    Neurosurgery; 2010 Feb; 66(2):233-46; discussion 246. PubMed ID: 20042986
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Influence of BMPs on the formation of osteoblastic lesions in metastatic prostate cancer.
    Feeley BT; Gamradt SC; Hsu WK; Liu N; Krenek L; Robbins P; Huard J; Lieberman JR
    J Bone Miner Res; 2005 Dec; 20(12):2189-99. PubMed ID: 16294272
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Bone morphogenetic proteins in breast cancer: dual role in tumourigenesis?
    Alarmo EL; Kallioniemi A
    Endocr Relat Cancer; 2010 Jun; 17(2):R123-39. PubMed ID: 20335308
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Transforming growth factor β and bone morphogenetic protein actions in brain tumors.
    Caja L; Bellomo C; Moustakas A
    FEBS Lett; 2015 Jun; 589(14):1588-97. PubMed ID: 25957771
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bone morphogenetic proteins mediate crosstalk between cancer cells and the tumour microenvironment at primary tumours and metastases (Review).
    Sun Z; Cai S; Zabkiewicz C; Liu C; Ye L
    Int J Oncol; 2020 Jun; 56(6):1335-1351. PubMed ID: 32236571
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hepatocyte growth factor up-regulates the expression of the bone morphogenetic protein (BMP) receptors, BMPR-IB and BMPR-II, in human prostate cancer cells.
    Ye L; Lewis-Russell JM; Davies G; Sanders AJ; Kynaston H; Jiang WG
    Int J Oncol; 2007 Feb; 30(2):521-9. PubMed ID: 17203235
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BMP modulators regulate the function of BMP during body patterning and disease progression.
    Yanagita M
    Biofactors; 2009; 35(2):113-9. PubMed ID: 19449438
    [TBL] [Abstract][Full Text] [Related]  

  • 12. BMP signaling and its paradoxical effects in tumorigenesis and dissemination.
    Zhang L; Ye Y; Long X; Xiao P; Ren X; Yu J
    Oncotarget; 2016 Nov; 7(47):78206-78218. PubMed ID: 27661009
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of RUNX3 in bone morphogenetic protein signaling in colorectal cancer.
    Lee CW; Ito K; Ito Y
    Cancer Res; 2010 May; 70(10):4243-52. PubMed ID: 20442291
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [BMP and cancer: the Yin and Yang of stem cells].
    Sagorny K; Chapellier M; Laperrousaz B; Maguer-Satta V
    Med Sci (Paris); 2012 Apr; 28(4):416-22. PubMed ID: 22549870
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transcriptional characterization of bone morphogenetic proteins (BMPs)-mediated osteogenic signaling.
    Peng Y; Kang Q; Cheng H; Li X; Sun MH; Jiang W; Luu HH; Park JY; Haydon RC; He TC
    J Cell Biochem; 2003 Dec; 90(6):1149-65. PubMed ID: 14635189
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone morphogenetic proteins in tissue engineering: the road from the laboratory to the clinic, part I (basic concepts).
    Bessa PC; Casal M; Reis RL
    J Tissue Eng Regen Med; 2008 Jan; 2(1):1-13. PubMed ID: 18293427
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of action of bone morphogenetic proteins in cancer.
    Davis H; Raja E; Miyazono K; Tsubakihara Y; Moustakas A
    Cytokine Growth Factor Rev; 2016 Feb; 27():81-92. PubMed ID: 26678814
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Extracellular BMP-antagonist regulation in development and disease: tied up in knots.
    Walsh DW; Godson C; Brazil DP; Martin F
    Trends Cell Biol; 2010 May; 20(5):244-56. PubMed ID: 20188563
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Bone morphogenetic proteins and their receptor signaling in prostate cancer.
    Ye L; Lewis-Russell JM; Kyanaston HG; Jiang WG
    Histol Histopathol; 2007 Oct; 22(10):1129-47. PubMed ID: 17616940
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunolocalization of BMPs, BMP antagonists, receptors, and effectors during fracture repair.
    Yu YY; Lieu S; Lu C; Miclau T; Marcucio RS; Colnot C
    Bone; 2010 Mar; 46(3):841-51. PubMed ID: 19913648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.